Hannes Teissl is the Chief Business Officer of Polpharma Biologics Group B.V. He has been with Polpharma Biologics since 2012 and was instrumental in establishing its foundations in Poland as well as the Netherlands (acquisition of Bioceros) and Switzerland (creation of Joint Venture Bioeq AG). Prior to joining Polpharma Biologics, Hannes has been an Executive Management Board Member at Sandoz, where he held several international management positions for over 22 years (e.g. Global Head of Biopharmaceuticals, Global Head of M&A, CEO of Sandoz Germany).